Lexagene Holdings Inc V.LXG

Primary Symbol: LXXGQ

Healthcare Medical Devices

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.

GREY:LXXGQ - Post by User

Lexagene Holdings Inc

Bullboard Posts

Post by Blackpanther3on Jan 21, 2018 12:01am

234 Views

Post# 27402594

This stock five bucks this time next year

the value of this company is no where close to what it’s really worth could be a 10 bagger read excerpt from its November news realease .

The market potential for LexaGene’s technology is significant: for example, the food safety market is expected to reach $21.4 billion by 2024, veterinary diagnostics is expected to reach $6.7 billion by 2021, water quality testing is expected to reach $3.5 billion by 2019 and infectious disease testing in human clinical diagnostics is estimated to reach $25.9 billion by 2022.

now that’s some big Baneros

Bullboard Posts

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity